FDA device reporting conference
This article was originally published in The Gray Sheet
Executive Summary
To discuss medical device reporting requirements for manufacturers, distributors and user facilities will be held July 13 in Rockville, Maryland. Topics to be addressed include adverse incident reporting, "guidelines, instructions and forms." The meeting also will address the electronic reporting pilot program and the partial draft standard for reporting events by electronic media. The meeting and availability of the standard on electronic data interchange (EDI) were announced in a June 25 Federal Register notice. For further information, contact Joan Rudick at 301/427-1156.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.